# China NMPA Drug Inspection - Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. - Amlodipine besylate tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-rongsheng-pharmaceutical-co-ltd/9cce04a0-8605-466f-9f39-5bf4f5bcdf56/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amlodipine besylate tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amlodipine besylate tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-rongsheng-pharmaceutical-co-ltd/ca65007b-7976-4dcd-a70a-7d9df193a3ae/